Skip to content

Ubiquiti Inc. UI Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
North America52%+6.1%
Europe, the Middle East and Africa (“EMEA”)39%-7.1%
Asia Pacific5%-16.7%
South America4%+33.3%

By product

See full
Enterprise technology91%+3.4%
Service provider technology9%-25.0%

Other financials

Income statement

See full
Revenue$788.2M+18.7%
Gross profit$370.7M+25.3%
Operating income$290.8M+28.2%
Net income$233.9M+29.6%
EPS (diluted)$3.86+29.5%

Balance sheet

See full
Cash & equivalents$368.7M+144%
Total debt$66.9M-82.6%
Total equity$1.2B+176%
Total assets$1.7B+32.1%

Cash flow

See full
Operating cash flow$167.8M+35.8%
CapEx$5.6M+96.6%
Free cash flow$162.2M+34.4%

Valuation

See full
Market cap$31.85B+32.4%
Enterprise value$31.55B+30.4%
P/E33.8×0.0×
P/S10.3×+0.9×

Profitability

See full
Gross margin46%+3.9pp
Operating margin35.8%+5.0pp
Net margin30.4%+6.8pp
FCF margin23.9%-7.6pp

Returns & leverage

See full
Return on equity115%-123pp
Debt / equity0.1×-0.8×
Current ratio3.6×+2.2×